ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,135Medicare Part D Prescriptions Filled, Including Refills

Rank: 71 out of 973

$538K Total Retail Price of All Prescriptions

Rank: 116 out of 973

489 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 489 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

18% of this provider’s 489 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 8,073 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
HYDROCODONE-ACETAMINOPHEN 920 543 S3 1 4
LISINOPRIL 496 309 2 3
LEVOTHYROXINE SODIUM 455 311 3 2
OMEPRAZOLE 420 262 4 5
PRAVASTATIN SODIUM 377 190 5 22
METFORMIN HCL 255 133 6 8
SIMVASTATIN 244 208 7 1
FUROSEMIDE 225 178 8 6
POTASSIUM CHLORIDE 223 140 9 9
AMLODIPINE BESYLATE 213 173 10 7
GABAPENTIN 196 120 11 12
TRAMADOL HCL 191 117 12 18
TRIAMTERENE-HCTZ 188 147 13 51
WARFARIN SODIUM 183 153 14 10
GLIPIZIDE 158 118 15 69
METOPROLOL TARTRATE 154 93 16 13
LOVASTATIN 147 94 17 38
HYDROCHLOROTHIAZIDE 142 109 18 11
CITALOPRAM HBR 134 99 19 14
CRESTOR 134 100 19 34
AMITRIPTYLINE HCL 128 103 R 21 52
LOSARTAN POTASSIUM 124 98 22 19
METOPROLOL SUCCINATE 119 82 23 17
NAPROXEN 119 59 23 94
ZOLPIDEM TARTRATE 115 76 25 20
ALLOPURINOL 110 81 26 29
CARVEDILOL 102 93 27 27
AZITHROMYCIN 101 71 28 47
ATORVASTATIN CALCIUM 99 69 29 15
ATENOLOL 98 82 30 16
TAMSULOSIN HCL 95 50 31 28
FENOFIBRATE 94 64 32 77
FENTANYL 90 78 S2 33 53
OXYCODONE HCL-ACETAMINOPHEN 88 47 S2 34 104
NEXIUM 85 35 35 30
PREDNISONE 85 60 35 33
ALENDRONATE SODIUM 82 75 37 24
LANTUS 75 51 38 39
LISINOPRIL-HYDROCHLOROTHIAZIDE 73 28 39 25
PROAIR HFA 72 58 40 54
FLUTICASONE PROPIONATE 70 41 41 35
SULFAMETHOXAZOLE-TRIMETHOPRIM 70 45 41 76
POLYETHYLENE GLYCOL 3350 68 19 43 36
NAMENDA 67 55 44 31
TRICOR 63 45 45 143
CLOPIDOGREL 63 48 45 44
DIGOXIN 61 61 47 32
ROPINIROLE HCL 59 59 48 72
ZETIA 57 46 49 81
SERTRALINE HCL 56 44 50 21
MELOXICAM 56 36 50 23
DONEPEZIL HCL 55 55 52 26
DIOVAN 54 41 53 63
FAMOTIDINE 52 19 54 61
OXYBUTYNIN CHLORIDE 52 46 54 92
FLUOXETINE HCL 51 33 56 56
BENICAR 51 51 56 231
SPIRONOLACTONE 50 20 58 49
TRAZODONE HCL 50 28 58 48
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 19, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.